NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

OpenAI Defends Decision to Allow Classified Use of ChatGPT

OpenAI, the maker of ChatGPT, has defended its decision to allow the technology to be used for classified assignments by the US Department of Defense. The company's CEO, Sam Altman, has faced criticism for announcing the deal with the Pentagon last week, shortly after US Defense Secretary Pete Hegseth designated Anthropic as a supply chain risk.

Altman has stated that he does not regret signing the deal with the Defense Department, but wishes that the announcement had been made in a more gradual manner to avoid the perception of opportunism. OpenAI has also emphasized that it does not get to make operational decisions on how its technology is used by the DoD.

OpenAI had signed a $200 million agreement with the Pentagon last year, which allowed the agency to use its models in non-classified use cases. The agreement was recently expanded to permit the use of models across classified networks. However, the Pentagon is also in talks with xAI, a company founded by Elon Musk, to allow for the use of its models across classified use cases.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

OpenAI had set three conditions for the use of its AI models by the Pentagon: no use of its AI for mass domestic surveillance, direct autonomous weapons systems, or high-stakes automated decisions. Altman has noted that xAI will not pose such requests to the Pentagon and will do whatever the agency says.

Investor Takeaway

Investors should be cautious of potential risks associated with OpenAI's partnership with the Pentagon.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.